Omega Tots Long Term Follow-up

Long-term Effects and Safety of DHA+AA Supplementation in Toddlerhood for Children Born Preterm

This is a continuation study to the Omega Tots trial (NCT01576783). The purpose of this study is to follow-up with participants of the original study to determine the long-term effect a daily fatty acid dietary supplement taken during toddlerhood might have on children born preterm now that they are 8.5-10.5 years old.

The overall objective with the present study is to determine the long-term effects of docosahexaenoic acid (DHA) plus arachidonic acid (AA) supplementation on general cognitive ability, language, and executive function, and to examine genetic explanations for treatment effects, through one comprehensive study visit with children and parents from the Omega Tots trial cohort (NCT01576783).

Inclusion Criteria:

• Previous participation in Omega Tots (NCT01576783).
• Current age of 8 years, 180 days to 10 years, 180 days.

Exclusion Criteria:

• Child in custody of children's services for their window of eligibility